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Abstract. 
 
Identiﬁcation of signaling molecules that reg-
ulate cell migration is important for understanding fun-
damental processes in development and the origin of 
various pathological conditions. The migration of Nara 
Bladder Tumor II (NBT-II) cells was used to determine 
which signaling molecules are speciﬁcally involved in 
the collagen-mediated locomotion. We show here that 
paxillin is tyrosine phosphorylated after induction of 
motility on collagen. Overexpression of paxillin mu-
tants in which tyrosine 31 and/or tyrosine 118 were re-
placed by phenylalanine effectively impaired cell motil-
ity. Moreover, stimulation of motility by collagen 
preferentially enhanced the association of paxillin with 
the SH2 domain of the adaptor protein CrkII. Muta-
tions in both tyrosine 31 and 118 diminished the phos-
photyrosine content of paxillin and prevented the for-
mation of the paxillin–Crk complex, suggesting that this 
association is necessary for collagen-mediated NBT-II 
cell migration. Other responses to collagen, such as cell 
adhesion and spreading, were not affected by these mu-
tations. Overexpression of wild-type paxillin or Crk 
could bypass the migration-deﬁcient phenotype. Both 
the SH2 and the SH3 domains of CrkII are shown to 
play a critical role in this collagen-mediated migration. 
These results demonstrate the important role of the 
paxillin–Crk complex in the collagen-induced cell mo-
tility.
Key words: cell migration • collagen • paxillin • ty-
rosine phosphorylation • Crk
 
Introduction
 
Cell migration is a fundamental aspect in numerous nor-
mal and pathological processes, including embryonic de-
velopment, wound healing, inflammation, and metastasis
of tumor cells (for reviews see Hay, 1995; Viebahn, 1995;
Birchmeier et al., 1996; Gumbiner, 1996). Various factors
in the cellular microenvironment participate in the regula-
tion of cell migration. These include soluble growth factors
and extracellular matrix (ECM)
 
1
 
 proteins whose pivotal
role has been clearly established using in vivo and in vitro
model systems (Schor, 1994; Boyer et al., 1996; Brand-
Saberi et al., 1996). Cell motility is also governed by the
cell interpretation of external signals, which are trans-
duced via multiple intracellular pathways. The motile pro-
cess is finally executed by different biochemical events
that modify the actin cytoskeleton and cell adhesion mole-
cules (Ingber, 1993). Because of its wide implications for
normal physiology and pathological conditions, consider-
able effort was directed towards the identification of intra-
cellular signaling molecules that may control the dynamics
of cell movement.
Induction of motility by the ECM is primarily associated
with integrin-mediated cell adhesion. Integrins constitute
a large family of 
 
a
 
/
 
b
 
 heterodimeric transmembrane recep-
tors that mediate interaction of cells with many different
ECM proteins (Hynes, 1992). The cytoplasmic tails of
integrins interact with cytoskeletal-associated molecules
providing a physical link between the ECM and the actin
cytoskeleton. Ligation of integrins by the ECM initiates a
cascade of intracellular signaling events involving the acti-
vation of tyrosine kinases and subsequent phosphorylation
of multiple cytoskeleton-associated substrates (Clark and
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strate; ECM, extracellular matrix; FAK, focal adhesion kinase; FN, fi-
bronectin; GFP, green fluorescent protein; LN, laminin; NBT-II, Nara
 
Bladder Tumor II; PL, poly-
 
L
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Brugge, 1995; Giancotti, 1997; Schoenwaelder and Bur-
ridge, 1999). These biochemical modifications ultimately
bring about diverse biological responses, including cell
survival, proliferation, and migration.
The interactions of cells with the ECM organize integrins
into specialized adhesive structures, termed focal adhe-
sions, which are sites where signaling molecules are highly
enriched (Jockusch et al., 1995; Miyamoto et al., 1995;
Burridge and Chrzanowska-Wodnicka, 1996). Integrin clus-
tering at these adhesive structures is dependent on the
proper assembly of the actin cytoskeleton that is regulated
by the Rho family of GTPases (Keely et al., 1998; Mackay
and Hall, 1998). Several signaling molecules that localize
at focal adhesions after integrin stimulation have been
implicated in cell motility; these include the nonreceptor
focal adhesion kinase (FAK) and c-Src family kinases.
FAK-deficient fibroblasts (Ilic et al., 1995) and Src kinase–
inactivated epithelial cells (Rodier et al., 1995) show de-
fective cell locomotion, whereas the overexpression of
these kinases facilitates cell movement (Rodier et al.,
1995; Cary et al., 1996; Gilmore and Romer, 1996). In ad-
dition, the protein tyrosine phosphatases Shp-2 (Yu et al.,
1998) and PTP-PEST (Angers-Loustau et al., 1999) also
have been implicated in the regulation of cell locomotion.
A role for these tyrosine kinases and phosphatases in cell
migration is also outlined by their substrates, including the
adaptor protein p130Cas (Crk-associated substrate) that
was recently shown to play a role in cell motility (Cary
et al., 1998; Klemke et al., 1998). However, the involve-
ment of other direct effectors of these kinases and phos-
phatases in cell motility remains to be determined.
Paxillin is a focal adhesion protein (Turner et al., 1990)
that was originally identified as a major tyrosine-phosphor-
ylated protein in cells transformed by the v-Src and v-Crk
oncogenes (Glenney and Zokas, 1989; Birge et al., 1993).
Paxillin becomes phosphorylated on tyrosine in response
to various physiological stimulants including bombesin,
PDGF, NGF, and angiotensin II (Zachary et al., 1993;
Rankin and Rozengurt, 1994; Melamed et al., 1995; Turner
et al., 1995), and in response to adhesion-mediated events
that are associated with remodeling of the actin cytoskele-
ton (Burridge et al., 1992; Turner, 1998). Evidence from in
vitro and in vivo studies has identified paxillin as a poten-
tial substrate for FAK (Bellis et al., 1995; Schaller and Par-
sons, 1995). These two proteins are coordinately phosphor-
ylated on tyrosine upon cell stimulation, are localized in
focal adhesions, and paxillin exhibits enhanced phos-
phorylation in FAK-overexpressing cells (for review see
Hanks and Polte, 1997). Paxillin can also serve as a sub-
strate for the protooncogene c-Abl in an integrin-depen-
dent manner (Lewis and Schwartz, 1998). Several struc-
tural features identify paxillin as an adaptor protein
capable of recruiting multiple signaling molecules (for re-
view see Turner, 1998). It contains a proline-rich region
that provides a potential binding site for the Src homology
(SH) 3 domain of Src family members (Weng et al., 1993)
and two pYXXP motifs that conform to consensus binding
sites for the SH2 domain of Crk and the protein tyrosine
kinase Csk (Birge et al., 1993; Sabe et al., 1994). The ty-
rosines at positions 31 and 118, in particular, have been
shown to be involved in the binding of Crk (Schaller and
Parsons, 1995). Paxillin also contains leucine rich motifs
(LD repeats) that can selectively bind to vinculin, FAK
(Brown et al., 1996), the FAK-related kinase Pyk2 (Salgia
et al., 1996), the papillomavirus oncoprotein E6 (Tong et al.,
1997), or to the recently identified p95PKL, or paxillin-
kinase linker that links paxillin to the p21 GTPase–acti-
vated kinase PAK, and the guanine nucleotide exchange
factor PIX (Turner et al., 1999). In the later case, it was
proposed that a protein complex composed of paxillin in
association with p95PKL/PAK/PIX is important for re-
modeling of the cytoskeleton. The ability of paxillin to in-
teract with numerous proteins suggests that paxillin may
mediate diverse signaling pathways. The functional signifi-
cance of these different associations of paxillin is yet to be
determined.
We have used the rat bladder carcinoma cell line Nara
Bladder Tumor II (NBT-II) to study the factors that
control ECM-mediated cell migration. NBT-II epithelial
cells are converted to motile cells during a process known
as the epithelium–mesenchymal transition (Boyer et al.,
1996). The induction of cell dispersion is specific for col-
lagens, whereas other ECM components such as fibronec-
tin (FN) and laminin (LN) only allow cell adhesion and
spreading (Tucker et al., 1990). Moreover, NBT-II cells
can be induced to scatter after stimulation with soluble
growth factors such as EGF and FGF (Boyer et al., 1989;
Vallés et al., 1990). It has been shown that a crucial com-
ponent in the scattering response of NBT-II cells to
growth factors is the Src kinase activity (Rodier et al.,
1995). However, this kinase activity is not necessary for
the initial collagen response (Petit et al., 1999). This raises
the question whether growth factors and ECM molecules
utilize the same signaling pathways to induce motility. In a
previous study, we demonstrated the importance of ty-
rosine phosphorylation for the collagen-induced migration
of NBT-II cells (Petit et al., 1999). In this report we sought
to identify the phosphotyrosinated molecules that are spe-
cifically regulated during the collagen-mediated motility
response. We found that tyrosine phosphorylation of two
major sites on the adaptor protein paxillin plays a central
role in the collagen-induced migration of NBT-II cells.
 
Materials and Methods
 
Reagents and Antibodies
 
Rat collagen type I from Sigma Chemical Co. was prepared as described
(Tucker et al., 1990). Fibronectin, laminin 1, and poly-
 
L
 
-lysine were ob-
tained from Sigma Chemical Co. Antibodies against FAK (clone 2A7)
used for immunoprecipitation and phosphotyrosine (clone 4G10) were
obtained from Upstate Biotechnology. Antipaxillin (clone 349), anti-FAK
(clone 77), anti-p130Cas (clone 21), and anti-Crk (clone 22) were obtained
from Transduction Laboratories. The polyclonal anti-chicken paxillin was
previously described (Bellis et al., 1995). Anti-p130Cas (C-20) used for
immunoprecipitation was from Santa Cruz Biotechnology, Inc. Anti-GFP
was obtained from Roche Molecular Biochemicals.
 
Constructions and Plasmids
 
cDNAs coding for chicken wild-type paxillin and the F118 mutant in the
pcDNA3 expression plasmid were previously described (Turner and
Miller, 1994; Bellis et al., 1995). PCR-based strategy was utilized to gener-
ate the F31 and the F31/118 mutants as follows. A first round of amplifica-
tion was made with primers 5
 
9
 
 TAATACGACTCACTATAGGG 3
 
9
 
 (T7
promoter primer) and 5
 
9
 
 GGGTAGGAGAAAGGCGTTT 3,
 
9
 
 using ei-
ther the wild-type or the F118 cDNAs as template. The resulting frag-
ments were used as primers for a second amplification round with oligo- 
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nucleotide 5
 
9
 
 GGGGGCTGCTCACCTCCCC 3
 
9
 
, containing the SacI
restriction site. The resulting products were digested with BamHI and
SacI and the fragments obtained, containing the mutated codons, were
used to replace the BamHI-SacI fragment of the full-length paxillin
cDNA. The BamHI-EcoRI fragments corresponding to full-length paxil-
lin F31 and F31/118 were subcloned into the pcDNA3 vector. GFP fusion
proteins were generated by PCR amplification with primers 5
 
9
 
 GCGGC-
CGCGTTCATCAACGG 3
 
9
 
 and 5
 
9
 
 CGGAATTCCGAAGAGTTT 3
 
9
 
,
containing the EcoRI restriction site, to eliminate the stop codon of paxil-
lin. The resulting fragment was digested with EcoRI and SacII and used to
replace the SacII-EcoRI fragment of the wt, F31, F118, or F31/118 con-
structs. The HindIII-EcoRI fragments corresponding to paxillin mutants
lacking stop codons were cloned into pEGFP-N1 (CLONTECH Labora-
tories). The validity of all PCR-generated constructs was confirmed by au-
tomatic sequencing (ABI PRISM Dye Terminator cycle sequencing kit;
Perkin Elmer). Plasmids encoding rat Crk-II, Crk-II (R38V), Crk-II
(W169L), untagged wild-type p130Cas, and p130Cas in-frame deletion of
its substrate domain (CAS
 
D
 
SD, amino acids 213–514) were provided by
Dr. R.L. Klemke (The Scripps Research Institute, La Jolla, CA) and pre-
viously described (Matsuda et al., 1993, 1994; Mayer et al., 1995).
 
Cell Culture and Transfections
 
The rat bladder carcinoma NBT-II cell line, originally established by
Toyoshima and colleagues (Toyoshima et al., 1971), was obtained from
Prof. M. Mareel (University Hospital, Ghent, Belgium). The cells were
grown in monolayers on tissue culture plastic in DME supplemented with
1% glutamine, 1% penicillin-streptomycin, and 10% heat-inactivated FCS
(complete medium). Cells stably expressing the paxillin constructs were
routinely grown in the presence of 400 
 
m
 
g/ml of active geneticin (G418,
GIBCO BRL; Life Technologies). The cells were maintained at 37
 
8
 
C in a
humidified atmosphere with 6% CO
 
2
 
.
To generate clones stably expressing the different paxillin constructs,
cells were transfected by the calcium phosphate method with 5 
 
m
 
g of the
expression plasmid pcDNA3 encoding the various cDNAs. Stable clones
were selected using complete medium containing 400 
 
m
 
g/ml active geneti-
cin and screened by Western blotting.
Transient transfections were done using Lipofectamine (GIBCO BRL)
following the manufacturer’s instructions. In brief, for migration assays,
NBT-II cells (1.7 
 
3 
 
10
 
5
 
 cells/35-mm plate) were transfected with 8 
 
m
 
l of
Lipofectamine and 2 
 
m
 
g of the expression vector, together with 0.2 
 
m
 
g of a
reporter plasmid encoding green fluorescent protein (GFP) (pEGFP-C1;
CLONTECH Laboratories). For immunoprecipitation experiments, 10 
 
m
 
g
of expression vectors was transfected per 100-mm plate. Cells were incu-
bated with the cDNAs for 5 h, washed, and analyzed 48 h later.
 
Immunofluorescence Microscopy
 
NBT-II cells were transiently transfected with the different paxillin-GFP
constructs for 48 h as described. Transfected cells were trypsinized and
seeded on collagen-coated dishes for 1 h at 37
 
8
 
C. The cells were fixed with
3.7% formaldehyde in PBS for 20 min, and permeabilized with 0.5% Tri-
ton X-100 in PBS for 2 min. GFP-transfected cells were visualized under a
fluorescent Leica microscope. Images were acquired with the Photoshop
software (Adobe Systems, Inc.) using a 63
 
3
 
 objective.
 
Cell Adhesion and Cell Spreading Assays
 
Initial cell adhesion and cell spreading assays were done as described with
minor modifications (Tucker et al., 1990). In brief, NBT-II cells were
trypsinized (0.05% trypsin/EDTA), resuspended in complete medium,
and washed three times in DME. For adhesion experiments, 5 
 
3 
 
10
 
5
 
 cells
were plated on small areas of bacterial petri dishes precoated with various
concentrations of collagen and saturated with BSA. After incubation at
37
 
8
 
C for 1 h, nonadherent cells were removed, and the remaining attached
cells were fixed with 3.7% formaldehyde in PBS. Cells were stained for 10
min with 5 mg/ml crystal violet and washed four times with H
 
2
 
O. The in-
corporated crystal violet was released in 10% acetic acid and quantified as
absorbance at 570 nm. To quantify cell spreading, fixed cells were counted
under a phase-contrast microscope. Spreading was calculated as the per-
cent cells that lost the round morphology. Each point represents duplicate
areas and is expressed as the mean of at least three independent experi-
ments 
 
6 
 
SD. Nonspecific cell adhesion was measured on BSA-coated ar-
eas and subtracted from each point.
 
Immunoprecipitations and Western Blots
 
Cells growing in complete medium were trypsinized, resuspended in com-
plete medium, and replated on plastic dishes precoated with poly-
 
L
 
-lysine
(200 
 
m
 
g/ml), collagen (10 
 
m
 
g/ml), fibronectin (10 
 
m
 
g/ml), or laminin 1 (10
 
m
 
g/ml). Because NBT-II cell migration requires serum components, it is
systematically added in the medium. Consequently, the basal levels of ty-
rosine phosphorylation increase without modifying the pattern of phos-
phorylated proteins. After incubation at 37
 
8
 
C for the indicated times, cells
were washed twice with ice-cold PBS. For Western blotting, total cellular
proteins were lysed with NP-40 buffer (1% NP-40, 50 mM Tris, pH 8, 150 mM
NaCl, 5 mM EDTA, 1 mM PMSF, 1 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml leupeptin,
and 100 mM sodium orthovanadate). For immunoprecipitation, Triton
buffer (1% Triton X-100, 10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM
EDTA, 1 mM PMSF, 1 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml leupeptin, and 100 mM
sodium orthovanadate) was used. Cell lysates were centrifuged for 20 min
at 14,000 rpm at 4
 
8
 
C. The cell lysates were incubated with the primary an-
tibody for 2 h at 4
 
8
 
C on a rocking platform, followed by incubation with
protein A–Sepharose precoupled with rabbit anti–mouse antibody, for an
additional 1 h at 4
 
8
 
C. Bead-bound complexes were washed three times
with cold lysis buffer and boiled with 1
 
3
 
 SDS sample buffer.
For Western blot analysis of total cell lysates or immunoprecipitates,
proteins were separated by SDS-PAGE under reducing conditions and
electrophoretically transferred onto polyvinylidene fluoride membranes
(Immobilon P; Millipore Corp.), blocked with 0.1% gelatin/0.1% Tween
20 in PBS, and subsequently incubated overnight at 4
 
8
 
C with the primary
antibody. Membranes were washed and incubated with either anti–mouse
or anti–rabbit IgG peroxidase conjugates. Proteins were visualized on Hy-
perfilm using enhanced chemiluminescence (ECL kit; Amersham Corp.).
Images were acquired using Photoshop software. Protein concentration
was determined using the Bradford protein assay (Bio-Rad Laboratories).
 
SH2 Binding Assays
 
The GST fusion protein containing the SH2 domain of rat c-Crk was a
gift of Dr. R.B. Birge (The Rockefeller University, New York, NY) and
was described (Birge et al., 1993). A cDNA construct encoding the SH2
domain of Grb2 fused with GST was provided by Dr. A. Ducruix (CNRS-
UPR 9063, Gif/Yvette). GST fusion proteins were expressed in exponen-
tially growing 
 
Escherichia coli
 
 cultures by addition of 1 mM isopropyl-
 
b
 
-thiogalactopyranoside. Bacterial lysates were incubated overnight at
4
 
8
 
C with glutathione-Sepharose 4B beads (Pharmacia Biotech Sverige).
Samples were analyzed by Coomassie staining to ensure equal amount of
GST fusion proteins. Cell lysates of transfected cells were prepared as for
immunoprecipitation, and incubated with equal amount of GST fusion
proteins bound to glutathione-Sepharose beads at 4
 
8
 
C for 2 h. Beads were
washed three times with lysis buffer and resuspended in 1
 
3
 
 SDS sample
buffer. Protein complexes were subjected to Western blot analysis.
 
Cell Migration Assay
 
To assay for random cell migration, freshly trypsinized cells were plated at
low density (10
 
5
 
) on 35-mm collagen-coated bacterial petri dishes. The as-
say is done in complete medium to optimize the migration of NBT-II cells,
as previously reported (Vallés et al., 1994). After 2 h, cells were placed on
the motorized stage of a Leica inverted microscope equipped with a cham-
ber providing a controlled temperature and CO
 
2
 
 concentration, and a
Princeton MicroMax CCD camera. Phase-contrast and fluorescent images
were obtained and analyzed with the Metamorph software (Metamorph
Imaging System; Universal Imaging Corp.) running on a PC workstation.
The motility of individual cells was evaluated by tracking their movement
over 12 h with images recorded every 4 min using the same software. The
average speed (
 
m
 
m/h) of locomotion was calculated as the total track
length divided by the number of hours recorded. For each experimental
condition, 20–30 cells were analyzed. In transient transfections with GFP,
only green fluorescent cells were followed.
 
Results
 
Paxillin and FAK Are Tyrosine-phosphorylated in
NBT-II Cells Plated on Collagen
 
Sustained migrations of NBT-II cells are induced by fibril-
lar collagen, whereas other components of the ECM like 
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FN, vitronectin, and LN are permissive for adhesion and
spreading. (Tucker et al., 1990). To identify cytoplasmic
molecules that are tyrosine-phosphorylated in association
with the persistent migratory phenotype induced by col-
lagen, NBT-II cells were plated onto dishes coated with ei-
ther collagen, FN, or LN and allowed to attach for 2 h in
the presence of serum that is necessary for the migratory
response. Cells plated onto PL served as control for nonin-
tegrin-mediated adhesion. Antiphosphotyrosine immu-
noblot analyses of total cell extracts (Fig. 1 A) revealed
proteins equally phosphorylated at a basal level on all ma-
trices and on PL, in contrast to FN and LN, cell adhesion
to collagen resulted in the significantly enhanced tyrosine
phosphorylation of two prominent 70–80-kD and 120-kD
molecular mass proteins (Fig. 1 A).
Various proteins were described to be tyrosine-phos-
phorylated after adhesion to matrix molecules, among
them were p130Cas (Nojima et al., 1995), FAK, and paxil-
lin (Burridge et al., 1992). To identify the proteins that are
tyrosine-phosphorylated in NBT-II cells in response to
collagen, immunoprecipitations were conducted with anti-
bodies to p130Cas, FAK, and paxillin with lysates from
cells plated on PL, FN, LN, and collagen, and analyzed for
phosphotyrosine content. As shown in Fig. 1 B, the ty-
rosine phosphorylation of p130Cas was similar whether
the cells were plated onto PL or after plating on the other
ECM components. In contrast, the tyrosine phosphoryla-
tion of FAK increased after adhesion of NBT-II cells to
collagen, but not after adhesion to FN or LN (Fig. 1 C).
The tyrosine phosphorylation of paxillin was also higher
on collagen, as compared with FN and LN (Fig. 1 D). The
same blots were reprobed with the corresponding antibod-
ies to verify that equal amounts of proteins were immuno-
precipitated (Fig. 1). Kinetic analyses of cells on colla-
gen verified that the tyrosine phosphorylation pattern of
p130Cas is not modulated at earlier times points (Fig. 1 E).
By immunodepletion experiments, we confirmed that
paxillin was the prominent phosphorylated pp80 band ap-
parent on the total lysate (data not shown), while other
unidentified minor components with similar 120-kD mi-
grations might be present. These results suggest that there
is a correlation between the collagen-induced tyrosine
phosphorylation of FAK and paxillin and the migratory
behavior of NBT-II cells.
 
Cell Migration of NBT-II Cells Correlates with 
Phosphorylation of Paxillin on Tyrosine Residues 31 
and 118
 
Since the phosphorylation of both FAK and paxillin in-
creased in NBT-II cells on collagen, and FAK was already
shown to be linked to cell migration in other systems (Ilic
et al., 1995; Cary et al., 1996), we focused our study on
paxillin. To investigate whether regulation of paxillin func-
tion by tyrosine phosphorylation was essential for the
NBT-II collagen-mediated events, we employed tyrosine
to phenylalanine mutants of the major phosphorylation
sites Y31 and Y118. cDNAs encoding the full-length
chicken paxillin and the F118 mutation have been de-
scribed previously (Turner and Miller, 1994; Bellis et al.,
1995). Using a PCR-based strategy, the F31 mutation was
created, alone or in combination with the F118 mutation,
as described in Materials and Methods. The resulting con-
structs were designated F31 and F31/118, respectively. Sta-
ble transfectants of NBT-II cells expressing the different
mutants were generated. Individual clones were screened
for paxillin expression by Western blotting with an anti-
body recognizing both species, and the levels of exogenous
paxillin were verified by immunoprecipitation with an an-
tibody specific to chicken paxillin (Bellis et al., 1995). The
selected clones contained three- to fivefold higher paxillin
levels as compared with parental ones (Fig. 2 A). In sepa-
rate transient transfection experiments using GFP fusion
forms of these mutants, we confirmed that the mutant pax-
illins displayed either less (F118-GFP or F31-GFP) or low
(Fx-GFP) tyrosine phosphorylation in response to col-
lagen (Fig. 2 B). The mutated proteins (Fig. 2 C, b–d) lo-
Figure 1. Adhesion of NBT-II cells on collagen induces tyrosine
phosphorylation of FAK and paxillin. NBT-II cells were allowed
to attach on either poly-L-lysine (PL), collagen-I (COL), fi-
bronectin (FN), or laminin-1 (LN) for 2 h. (A) Total cellular ly-
sates from stimulated cells were subjected to immunoblot analy-
sis with antiphosphotyrosine antibody. Lysates prepared from
cells stimulated by the different matrix molecules were immuno-
precipitated with anti–p130Cas (B), anti–FAK (C), or antipaxil-
lin (D) antibodies, and then immunoblotted with antiphosphoty-
rosine antibody or with the corresponding antibodies. (E) Time
course of p130Cas and paxillin tyrosine phosphorylation. Total
cellular lysates from cells stimulated with collagen for the indi-
cated times were processed as above. The horizontal bars indi-
cate the migration of molecular mass standards. The arrowheads
point to the position of FAK and paxillin. 
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calized to cell–substrate adhesion sites similar to wild-type
paxillin (Fig. 2 C, a).
Independent clones expressing paxillin mutants were
used in standard adhesion and spreading assays. These ex-
periments revealed rates of attachment on collagen for the
different clones that did not differ to that of cells express-
ing the wild-type protein (Fig. 3 A). These results are in
agreement with previous results showing that these muta-
tions in paxillin do not interfere with the adhesion of
CHO-K1 cells on fibronectin (Brown et al., 1998). The dif-
ferent clones also displayed comparable initial rates of
spreading on collagen when compared with control mock-
transfected cells (Fig. 3 B). Therefore, phosphorylation
of tyrosine residues 31 and 118 on paxillin may not be
directly involved in the regulation of cell adhesion or
spreading of NBT-II cells on collagen.
To assess the migratory behavior of NBT-II cells ex-
pressing paxillin mutants on collagen, random migration
assays were performed that measure the capacity of cells
to move on a given substrate. The movement of individual
cells was monitored at 4-min intervals for 12 h, and the mi-
gration rate was quantified as the total distance of migra-
tion by one cell divided by the time of recording. The
results in Fig. 4 show that expression of the double muta-
tions F31/118 (clones Fx1-3) resulted in a significant de-
crease in the migration of the cells on collagen (50–70%
reduction for different clones) as compared with control
(clones C1 and C2), whereas expression of the single mu-
tations (clones F118-1, 2 and F31-1, 3) had a less pro-
Figure 2. Expression and localization of wild-type and mutant
forms of paxillin in NBT-II cells. (A) Equal amounts of total cell
lysates from stable mock-transfected cells (clone C1), wild-type
paxillin (clones P1 and P2), mutant F31 (clones F31-1 and F31-2),
mutant F118 (clones F118-2 and F118-3), and double mutant F31/
118 (clones Fx1 and Fx3) cells were (a) subjected to immunoblot
analysis with antipaxillin antibodies or (b) immunoprecipitated
with anti-chicken paxillin antibodies followed by antipaxillin im-
munoblots. (B) Lysates prepared from cells transiently trans-
fected with the paxillin-GFP constructs and stimulated by col-
lagen were immunoprecipitated with anti–GFP antibodies and
immunoblotted with anti–GFP and antiphosphotyrosine (Ptyr)
antibodies. (C) To localize the transfected paxillin forms, cells
were transiently transfected with paxillin-GFP constructs for 48 h,
allowed to spread on collagen-coated dishes for 1 h and then
fixed (a, pax-GFP; b, F31-GFP; c, F118-GFP; and d, F31/118-
GFP). Note that the GFP fluorescence localized to cell-substrate
sites (arrows in inserts) in addition to a diffuse pattern in the cy-
toplasm. Bar, 20 mm.
Figure 3. Adhesion and spreading of clones expressing wild-type
and mutant forms of paxillin are similar on collagen. (A) Mock-
transfected (clone C1) and cells stably transfected with wild-type
(clone P1), or mutant forms of paxillin F31 (clone F31-1), F118
(clone F118-2), or F31/118 (clone Fx1) were allowed to adhere on
plates coated with the indicated concentrations of collagen for 1 h
at 378C. Absorbance values corresponding to crystal violet up-
take were determined for each point and expressed as percent
adhesion. (B) Cell spreading was quantified by allowing cells to
adhere on plates coated with 20 mg/ml collagen for the indicated
times. Cell spreading was determined by calculating the percent-
age of spread cells at each time point. Values represent the mean
of three independent experiments carried out in duplicate 6 SD.
Selected clones are representative of all the tested clones. 
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nounced effect (Fig. 4 A). Overexpression of the wild-type
construct produced a slight increase in migration of NBT-
II cells (clones P1 and P2 compared with clones C1 and
C2). Visualization of the tracks formed by individual cells
clearly points to marked differences in the migratory be-
havior of these clones: a dramatic reduction in the persis-
tence of locomotion for F31 and F31/118 mutants (Fig. 4
B, e–h) and less pronounced for F118 mutants (Fig. 4
B, d), as compared with control cells (Fig. 4 B, a). More-
over, although F31/118-transfected cells remained essen-
tially stationary, they exhibited active membrane dynam-
ics (data not shown), suggesting that the defect is specific
to cell locomotion. Similar dominant-negative effects were
obtained in transient transfections of the different con-
structs when coexpressed with GFP to visualize the trans-
fected cells or with GFP-fusion proteins (Fig. 8; and data
not shown). These results show that mutations in both ty-
rosine residues result in the strong reduction of cell motil-
ity and suggest that phosphorylation of these residues may
be necessary for the collagen-induced migration of NBT-II
cells. It should be noted that because of the high expres-
sion levels of endogenous paxillin, the dominant-negative
effect of the mutant proteins was not able to completely
abolish cell motility.
 
Crk Binding to Paxillin Is Impaired in
F31/118-expressing Cells
 
Tyrosine residues 31 and 118 of paxillin reside within a
YXXP motif that corresponds to an optimal Crk-SH2-
binding sequence (Birge et al., 1993). When these residues
are phosphorylated, they become effective binding sites
for the adaptor protein Crk (Birge et al., 1993; Schaller
and Parsons, 1995). To determine whether paxillin associ-
ates with Crk in NBT-II cells, cell lysates from parental
cells adhering either to collagen or other nonpermissive
substrates like PL, FN, and LN were immunoprecipitated
with anti–Crk antibodies and immunoblotted after SDS-
PAGE with antipaxillin antibodies (Fig. 5). As shown in
Fig. 5 A, Crk and paxillin strongly associated in NBT-II
cells upon collagen stimulation, although some interaction
was also detectable on PL, FN, and LN. The associations
on FN and LN are probably due to the small phoshoryla-
tion content of paxillin obtained on these substrates (Fig.
1) as a consequence of a brief scattering effect seen before
cell contacts are reformed. Kinetics studies demonstrated
an increase in paxillin–Crk association in a time-depen-
dent manner after stimulation with collagen (Fig. 5 B).
Conversely, Crk and p130Cas interactions although de-
tectable on PL, decreased in time upon collagen stimula-
tion. These results suggest that both p130Cas and paxillin
can potentially associate with Crk in unstimulated NBT-II
cells, but that upon motility induction by collagen, Crk will
preferentially bind to paxillin.
To further define the molecular basis of the interaction
between paxillin and Crk, we used the SH2 domain of
CrkII (Crk-SH2) expressed as a GST fusion protein and
immobilized on glutathione-Sepharose beads. Lysates of
parental cells plated on collagen or PL were precipitated
with GST-fusion proteins of Crk-SH2, Grb2-SH2, or GST
alone, and the bound proteins were separated by SDS-
PAGE and immunoblotted with antibodies to phosphoty-
 
rosine, paxillin, and p130Cas. As shown in Fig. 6, Crk-SH2
bound paxillin in the collagen-induced cell lysate and, to a
much lesser extent, in the lysates from cells plated on PL.
This fraction of paxillin that bound to Crk-SH2 in cells
plated on PL could be due to the background levels of ty-
rosine-phosphorylated paxillin present in these cells (Fig.
6, left panel; see also Fig. 1 A). Paxillin failed to bind GST
alone or the SH2 domain of Grb2 that belongs to the fam-
ily of SH2/SH3-containing signaling molecules. Therefore,
in NBT-II cells, paxillin appears to associate with the SH2
domain of Crk, and this interaction is increased after col-
lagen stimulation. The results in Fig. 6 also show that
the SH2 domain of Crk was able to bind p130Cas from
both stimulated and unstimulated NBT-II cells. Taken to-
gether, these results support the notion that the full-length
c-Crk preferentially binds to tyrosine-phosphorylated pax-
illin upon stimulation of cells with collagen. On the other
hand, the SH2 domain of Crk can potentially bind to both
p130Cas and paxillin.
Next, we tested the hypothesis that the inability of cells
expressing mutant paxillin to move on collagen results
from an altered association of paxillin with the SH2 do-
main of Crk. To this end, we analyzed the binding of Crk
to the different paxillin mutants, under the experimental
conditions used in the migratory assays. To discriminate
between the exogenous mutants and the endogenous pax-
illin, the association between the SH2 domain of Crk and
the paxillin mutants was examined in transient transfec-
tion experiments using the various GFP-paxillin con-
structs. The motile behavior of NBT-II cells trans-
fected  with GFP-paxillin constructs was the same as that
of the nontagged paxillin constructs cotransfected with
GFP (data not shown). Cell lysates of transiently trans-
fected cells stimulated with collagen were incubated with
GST fusion proteins of the Crk-SH2 or with GST alone,
and precipitates were analyzed by Western blotting using
antipaxillin antibodies (Fig. 7 A). As expected, the wild-
type form of paxillin bound to the SH2 domain of Crk
(Fig. 7 A). In cells expressing the F31/118-GFP construct
(Fx-GFP), Crk binding was abolished, whereas cells ex-
pressing the constructs containing single mutations in pax-
illin (F118-GFP and F31-GFP) retained the capacity to
bind to the SH2 domain of Crk. These different forms of
Figure 4 (continues on facing page). 
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Figure 4. Random cell migration is reduced in cells expressing the F31/118 mutations on paxillin. Stable transfectants were allowed to
attach on plates coated with 20 mg/ml of collagen for 2 h. Cell motility was evaluated by tracking individual cells for 12 h with a Leica in-
verted microscope connected to a computer using the Metamorph software. (A) Values obtained from measuring the tracks of cells are
presented as micrometers per hour. Each bar represents the mean of at least three independent experiments 6 SD. (B) Representative
migration tracks formed by clones C1 (a), P1 and P2 (b and c), F31-1 and F31-3 (e and f), F118-1 (d), and Fx2 and Fx3 (g and h). 
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paxillin failed to bind GST alone. Coimmunoprecipitation
experiments were also done from intact cells transfected
with either the wild-type paxillin-GFP or the mutant F31/
118-GFP form. As shown in Fig. 7 B, only the transfected
wild-type paxillin and not the double mutant form was ca-
pable of interacting with endogenous Crk. These results
demonstrate that the paxillin F31/118 mutations can block
the association of paxillin with the SH2 domain of endoge-
nous Crk and, thus, may account for the reduced migra-
tion in these cells.
 
Involvement of Crk in the Collagen-induced Migration 
of NBT-II Cells
 
To further investigate the involvement of Crk in the col-
lagen-induced migration, NBT-II cells were transfected
with constructs encoding either the wild-type form of
CrkII, or a point mutant of the SH2 domain together with
a GFP plasmid, and only green fluorescent cells were ana-
lyzed for cell migration. The point mutation of Crk at resi-
due 38 (arginine to valine, R38V) abolishes the function of
the SH2 domain and prevents its binding to tyrosine-phos-
phorylated substrates, including paxillin (Matsuda et al.,
1993; and our unpublished observations). The data in Fig.
8 show that transient expression of the wild-type CrkII re-
sulted in an increase in cell migration, compared with cells
expressing an empty vector. In contrast, the migration of
cells overexpressing the R38V mutant of the CrkII SH2
was greatly impaired (Fig. 8). These results suggest that
Crk is implicated in the collagen-mediated migration of
NBT-II cells, and that it requires a functional SH2 domain.
Some adaptor proteins mediate their effect by coupling
tyrosyl-phosphorylated proteins through their SH2 do-
main to downstream effector molecules using their SH3
domains. Since the SH3-(N) domain of Crk was shown to
be involved in regulating the migration of COS cells
(Klemke et al., 1998), we studied the role of CrkII SH3 do-
main in collagen-induced NBT-II cell migration. A point
mutant of the SH3-(N) domain of CrkII (W169L) that
cannot bind to effector molecules (Matsuda et al., 1994)
was transfected in NBT-II. As shown in Fig. 8, expression
of this mutant did not promote an increase in cell migra-
tion, unlike the wild-type CrkII, suggesting a role for the
SH3-(N) domain in the mediation of NBT-II cell migra-
tion on collagen.
To further establish a link between paxillin and Crk in
the collagen-induced migration of NBT-II, we examined
whether Crk could bypass the motility-deficient pheno-
type observed in cells expressing the F31/118 mutations in
paxillin. Stable NBT-II clones expressing the F31/118 mu-
tations in paxillin were cotransfected with wild-type CrkII
and GFP, and their migration on collagen was determined.
Figure 5. Adhesion on collagen enhances the association of
CrkII with paxillin in NBT-II cells. (A) Total cell lysates pre-
pared from cells plated on PL, collagen, FN, or LN for 2 h were
immunoprecipitated with anti–Crk antibodies, subjected to SDS-
PAGE and revealed with antipaxillin and anti–Crk antibodies.
(B) Total cell lysates prepared from cells plated on either PL or
collagen for 30, 60, 90, 120 min at 378C were immunoprecipitated
with anti–Crk antibodies. Total lysates (left panels) and immuno-
precipitates (right panels) were subjected to SDS-PAGE and im-
munoblotted with antipaxillin, anti–p130Cas and anti–Crk anti-
bodies. Note the presence of the CrkII protein doublet.
Figure 6. Plating on collagen increases the association of ty-
rosine-phosphorylated paxillin with GST-CrkSH2 in NBT-II
cells. NBT-II cells were plated on either PL or collagen for 90
min at 378C. Cell lysates were incubated for 2 h at 48C with GST-
CrkSH2, GST-Grb2SH2 fusion proteins or GST alone that were
previously immobilized on glutathione-Sepharose 4B beads. To-
tal cell lysates (left panel) and the bound proteins (right panel)
were separated by SDS-PAGE and immunoblotted with an-
tiphosphotyrosine, antipaxillin and anti–p130Cas antibodies. The
arrows indicate the position of p130Cas (upper) and paxillin
(lower). 
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Expression of CrkII in such cells increased their rate of
migration in two independent clones (Fig. 9). Transfection
of wild-type paxillin into cells expressing the F31/118 pax-
illin mutation also could have rescued the dominant-nega-
tive effect (Fig. 9). In addition, transient cotransfection of
wild-type CrkII and the F31/118-GFP construct showed
that the double mutant form of paxillin could diminish the
Crk-induced migration (Fig. 8). Taken together, these re-
sults indicate that wild-type CrkII is able to bypass the mo-
tility-deficient phenotype of the F31/118 paxillin muta-
tions and demonstrate that CrkII acts downstream of
paxillin.
 
Discussion
 
In this study, we provide evidence demonstrating that ty-
rosine phosphorylation of two major phosphorylation sites
of the adaptor protein paxillin plays a central role in the
collagen-induced migration of NBT-II cells. The rat blad-
der carcinoma NBT-II cell line represents an in vitro
model for the study of factors that control the intercon-
version between the epithelial and mesenchymal states
(Boyer et al., 1996). In these cells, stimulation by collagens
through the 
 
a
 
2
 
b
 
1 integrin results in the loss of epithelial
features and the acquisition of mesenchymal properties in-
cluding cell locomotion (Tucker et al., 1990; Vallés et al.,
1996). In contrast, other components of the ECM such as
FN or LN only allow cell adhesion and spreading. There-
fore, we have used this dependence on the type of sub-
strate to identify the signaling molecules that are activated
during the migratory response of NBT-II cells.
We have previously shown the importance of tyrosine
phosphorylation during the collagen-induced migration of
NBT-II cells (Petit et al., 1999). Comparison of the ty-
rosine phosphorylation pattern of NBT-II cells stimulated
with different ECM proteins revealed that both FAK and
paxillin were specifically phosphorylated on tyrosine after
collagen induction. FAK-tyrosine phosphorylation has
been associated with cell migration in many cell types, and
FAK-deficient fibroblasts exhibit a reduced motility (Cary
Figure 7. CrkII binding to paxillin is impaired in F31/118-trans-
fected cells. (A) NBT-II cells were transiently transfected for 48 h
with constructs encoding the different mutant forms of paxillin
fused to GFP. Cells were stimulated on collagen for 90 min at
378C, and cell lysates were incubated for 2 h at 48C with GST-
CrkSH2 fusion protein, or with GST alone, immobilized on glu-
tathione-Sepharose 4B beads. Total cell lysates (left panel) and
bound proteins (right panel) were separated by SDS-PAGE and
immunoblotted with antipaxillin antibodies. (B) Cells transfected
for 48 h with wild-type paxillin (pax-GFP) or the double mutant
form (F31/118-GFP) were collagen stimulated, and the total cell
lysates were incubated for 2 h with anti–GFP antibodies. After
SDS-PAGE separation, immunoblots were revealed with anti-
paxillin and anti–Crk antibodies.
Figure 8. CrkII promotes cell migration of NBT-II cells on col-
lagen. NBT-II cells were transiently transfected for 48 h with
wild-type paxillin (Pax wt), CrkII, double paxillin mutants (F31/
118), CrkII mutants (CrkII R38V and CrkII W169L), CAS de-
leted of its substrate domain (CasDSD), together with a vector
encoding GFP (10:1 ratio) or CrkII together with GFP-tagged
F31/118 (Fx-GFP). (A) Cells were plated on collagen for 2 h at
378C, and cell motility was evaluated by tracking individual green
fluorescent cells for 12 h as described in Fig. 4. Values obtained
from the quantification of the lengths of tracks are presented as
mm/h. Each bar represents the mean of at least three indepen-
dent experiments 6 SD. (B) Lysates obtained from cells trans-
fected with the different constructs were analyzed for expression
of p130Cas, paxillin, and Crk with specific antibodies. 
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et al., 1996; Gilmore and Romer, 1996). Induction of FAK
phosphorylation was also observed in NBT-II cells in-
duced to scatter with EGF (Boyer et al., 1997). Therefore,
FAK is a common target for growth factors and the ECM
in the induction of NBT-II cell migration. Tyrosine phos-
phorylation of paxillin was shown to correlate with the mi-
gratory behavior of human melanoma cells on vitronectin
(Aznavoorian et al., 1996) and with the invasive property
of cervical and prostate cancers (Aprikian et al., 1997; Mc-
Cormack et al., 1997). In NBT-II cells, stimulation with
collagen greatly enhanced tyrosine phosphorylation of
paxillin in contrast to cells seeded on other ECM compo-
nents. This increased tyrosine phosphorylation on collagen
was not due to differential spreading of cells on the vari-
ous substrates, since time course analyses showed the
same differences in tyrosine phosphorylation on these sub-
strates (data not shown). Interestingly, paxillin was not
phosphorylated on tyrosine after EGF-induced scattering
of NBT-II cells (Boyer et al., 1997; Petit, V. and A.M.
Vallés, unpublished results). Therefore, it appears that
phosphorylation of paxillin on tyrosine is specific for the
motile response induced by collagen.
To address the role of paxillin tyrosine phosphorylation
in cell migration, we examined the consequences of over-
expressing mutant forms of the major tyrosine phosphory-
lation sites Y31 and Y118. These tyrosine residues previ-
ously were shown to be phosphorylated upon adhesion to
FN (Bellis et al., 1997). Our study demonstrates that phos-
phorylation of both Y31 and Y118 is required for an opti-
mal motile response of NBT-II cells on collagen. Single
mutations (F31 or F118) on paxillin produced a mild dom-
inant-negative effect on migration with the strongest in-
hibitory effect obtained when phosphorylation on both ty-
rosine residues was eliminated. However, other responses
to collagen such as cell adhesion and spreading were not
affected by these mutations. Recent mutational analysis of
paxillin identified the phosphorylation sites LIM2T403
and LIM3S481, rather than Y31 and Y118, as playing a
role in these events (Brown et al., 1998). Moreover, cor-
rect targeting of paxillin to focal adhesions and to focal
complexes does not depend on the phosphorylation of ty-
rosine residues Y31 and Y118 (Bellis et al., 1995; Brown
et al., 1998; this work). These data suggest that the muta-
tions on F31/118 in paxillin exert a dominant-negative ef-
fect by substituting for endogenous paxillin at active sites
in the cell, thereby preventing the recruitment of specific
cellular proteins necessary for the initiation of cell migra-
tion. These results also support the notion that phosphory-
lation of paxillin on distinct residues may serve as a major
mechanism for modulating cellular functions like adhesion
and migration.
It is well established that phosphorylated tyrosine resi-
dues provide docking sites for the interaction with pro-
teins that possess SH2 domains (Koch et al., 1991). The ty-
rosine phosphorylation of paxillin at residues 31 and 118
creates binding sites for the SH2 domain of the adaptor
protein Crk (Birge et al., 1993; Schaller and Parsons,
1995). We showed that the formation of the paxillin–Crk
complex is required for the migration of NBT-II cells. In
unstimulated cells, paxillin only weakly associates with
CrkII. This association increases after collagen stimula-
tion, when paxillin becomes highly phosphorylated and
the cells are induced to move. When the cells overexpress
the F31/118 mutant proteins, however, formation of the
paxillin–Crk complex is prevented and consequently, cell
locomotion is inhibited. Moreover, the decreased migra-
tion of NBT-II cells overexpressing F31/118 mutants can
be rescued by overexpressing wild-type CrkII. Signifi-
cantly, overexpression of the wild-type CrkII increases the
rate of locomotion of NBT-II cells over that of control
cells, but the mutant form of CrkII in which the SH2 do-
main is altered cannot. Taken together, these data support
a role for paxillin–Crk complex in the collagen-induced
cell migration. It should be noted that overexpression of
paxillin did not significantly enhance the motile response
to collagen, whereas Crk overexpression greatly stimu-
lated it. This implies that the regulation of paxillin tyrosine
phosphorylation by collagen is central in the control of the
motile response. In addition, this suggests that Crk, but
Figure 9. CrkII can rescue the migration deficiency of F31/118-
transfected cells. Two stable transfected cell lines (clones Fx1 and
Fx2) expressing the F31/118 mutations were transiently trans-
fected for 48 h with wild-type CrkII or paxillin (Pax), together
with a vector encoding GFP (10:1 ratio). (A) Cells were allowed
to attach to collagen for 2 h at 378C and cell motility determined
as described in Fig. 4. Values obtained from the quantification of
track paths are represented in micrometers per hour. Each bar
represents the mean of at least three independent experiments 6
SD. (B) Lysates obtained from cells transfected with the different
constructs were analyzed for expression of paxillin and Crk with
specific antibodies. 
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not paxillin could be a limiting factor in the induction of
cell motility in NBT-II cells. Residue Y118 of paxillin can
also recruit the tyrosine kinase Csk via its SH2 domain
(Sabe et al., 1995). Although the interaction between pax-
illin and Csk was not examined in the present study, we
cannot exclude a role for this kinase in the collagen-medi-
ated response since it has been described that Crk and Csk
could compete for the binding to paxillin (Sabe et al.,
1995).
Recently, the adaptor protein Crk was identified as a
mediator of cell locomotion through association with
p130Cas, another SH2-binding protein (Cary et al., 1998;
Klemke et al., 1998). However, in NBT-II cells, the expres-
sion of a dominant form of p130Cas, CAS
 
D
 
SD, had only a
slight inhibitory effect on random cell migration as com-
pared with the paxillin double mutant (Fig. 8). Although
p130Cas is expressed in NBT-II cells, its basal levels of ty-
rosine phosphorylation remain unchanged, regardless of
ECM stimulation. Interestingly, p130Cas could be found
associated with Crk in unstimulated NBT-II cells but the
association decreased upon collagen stimulation. In con-
trast, the paxillin–Crk complex, which was detected before
collagen stimulation, greatly increased with time. Whereas
the paxillin–Crk complex augmented, that of CAS/Crk de-
creased after collagen stimulation. The selectivity of the
paxillin–Crk complex in mediating NBT-II cell migration
could be cell type–specific. For example, it has been shown
that the activation of 
 
b
 
1-integrin in a T cell line induced
the association of CrkL with p110 HEF1, a p130Cas-like
docking protein, whereas in a megakaryoblastic cell line,
CrkL associated with p120 Cbl. While both p110 HEF1
and p120 Cbl are present in the two hematopoietic cell
lines, CrkL associated preferentially with a single tyrosine
phosphoprotein (de Jong et al., 1997). Alternatively, the
choice between different target proteins like paxillin or
p130Cas could depend on the type of inducing molecule.
This is the case in serum-starved rat-1 fibroblasts where
p130Cas, but not paxillin association to CrkII, is regulated
by insulin (Nakashima et al., 1999). Stimulatory signals can
also regulate the switch of one binding protein for another,
as seen for Crk change in association from p130Cas to
p120 Cbl upon EGF induction (Khwaja et al., 1996). While
in other cases, the stimuli-dependent dephosphorylation
of substrates like p130Cas promoted the dissociation from
Crk and its association with other docking proteins
(Sorokin and Reed, 1998). However, the two possibilities
must not be mutually exclusive.
In the present study we show that the NH
 
2
 
-terminal SH3
domain of Crk is also necessary for the Crk-induced pro-
motion of migration in NBT-II cells as observed in COS
cells (Klemke et al., 1998). Numerous cellular proteins
have been recently identified on the basis of their interac-
tion with the SH3-(N) domain of Crk, and are thus likely
to be downstream effectors in this signaling pathway.
Among these is the cellular protein DOCK180, which is a
downstream target of integrin-mediated signaling (Hase-
gawa et al., 1996; Kiyokawa et al., 1998b). DOCK180 can
bind directly and activate the small GTPase Rac1 (Kiyo-
kawa et al., 1998a). Importantly, activation of Rac1 pro-
motes the migration and invasion of mammary epithelial
cells and the scattering of MDCK cells on collagen (Keely
et al., 1997; Sander et al., 1998). Tyrosine phosphoryla-
tion–dependent paxillin–Crk complexes could possibly
link integrin activation to downstream targets via their in-
teraction with DOCK180.
Alterations in signal transduction pathways have been
shown to contribute to initiation and progression of can-
cer. Specifically, the anchorage-independent growth of
malignant cells has implicated changes in integrin-medi-
ated signaling pathways (for reviews see Schwartz, 1997;
Keely et al., 1998). For example, constitutive activation of
Rho, on an integrin pathway, has been suggested to
contribute to cell transformation (Schwartz et al., 1996).
Likewise, disregulation of the integrin-linked kinase ILK,
by overexpression, induces anchorage-independent cell
growth and tumorigenicity (Wu et al., 1998). Similar ef-
fects are obtained with a constitutive active form of FAK
(Wu et al., 1998). Interestingly, while paxillin phosphory-
lation by the c-Abl tyrosine kinase is integrin-dependent
(Lewis and Schwartz, 1998), in 
 
BCR/ABL
 
-transformed
cells, paxillin was found phosphorylated and constitutively
associated with the oncogenic variant p120
 
BCR/ABL
 
 (Salgia
et al., 1995). Moreover, it recently has been proposed that
binding of a viral oncoprotein, the human papillomavirus
HPV16 E6 gene product, to paxillin could disrupt its nor-
mal function and thereby contribute to neoplastic trans-
formation (Tong and Howley, 1997; Vande Pol et al.,
1998). Together, these findings support a model where
promiscuous activation of integrin-dependent signaling by
oncogenes acting on cytoskeletal proteins could provide a
molecular basis for the aberrant behavior of transformed
cells during the acquisition of invasive properties.
In conclusion, we have implicated the paxillin–Crk sig-
naling pathway in the collagen-mediated motility response
of NBT-II cells. We demonstrated that the collagen-
induced phosphorylation of tyrosines 31 and 118 of paxil-
lin is necessary for the interaction of paxillin with the
adaptor protein CrkII. Inhibition of the formation of this
complex by point mutations on either paxillin or CrkII re-
sulted in reduced cell locomotion on collagen. These de-
fects could be rescued by overexpression of wild-type pax-
illin. Moreover, over-repression of CrkII also restored the
motile response, indicating that CrKII is downstream of
paxillin in the signaling pathway. Finally, we demonstrated
that the SH3-(N) domain of CrkII is necessary for the mo-
tile response to collagen probably by its interaction with
downstream motility effector molecules. Therefore, the
ability of paxillin to interact with various signaling mole-
cules makes this adaptor protein a central element of regu-
lation where different integrin signaling pathways could
become integrated.
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